Without therapeutic drug monitoring, there is no personalized cancer care
Clin Pharmacol Ther
.
2013 Mar;93(3):228-30.
doi: 10.1038/clpt.2012.243.
Author
J H Beumer
1
Affiliation
1
Molecular Therapeutics and Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. beumerj@gmail.com
PMID:
23419487
DOI:
10.1038/clpt.2012.243
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Drug Monitoring*
Humans
Neoplasms / drug therapy*
Precision Medicine*
Grants and funding
P30-CA47904/CA/NCI NIH HHS/United States
U01-CA099168/CA/NCI NIH HHS/United States